Insider Transactions and Holdings
-
Entity Type
-
Individual
-
Role
-
Director
-
Issuer Symbol
-
BDSX on Nasdaq
There are no Buy or Sell transactions made by Matthew Strobeck since 06 Jan 2025
Holdings reported by Matthew Strobeck for BIODESIX INC
| Security |
Num Shares |
Value |
Price $ |
Transaction Date |
Ownership |
Underlying Class |
Underlying Amount |
| Common Stock |
2,606,879 |
$3,644,156 |
$1.40 |
05 Nov 2024 |
By Birchview Fund LLC |
|
|
| Common Stock |
2,542,928 |
$3,455,839 |
$1.36 |
05 Nov 2024 |
Direct |
|
|
| Common Stock |
119,003 |
$161,725 |
$1.36 |
05 Nov 2024 |
By UTMA Account |
|
|
| Common Stock |
89,673 |
$125,354 |
$1.40 |
05 Nov 2024 |
By Birchview Capital Separately Managed Account |
|
|
| Common Stock |
40,665 |
$55,264 |
$1.36 |
05 Nov 2024 |
By Clajer Capital LLC |
|
|
| Restricted Stock Units |
80,525 |
$22,565 |
$0.4200 |
20 May 2025 |
Direct |
Common Stock |
|
| Stock Options (Right to Buy) |
42,010 |
|
|
20 May 2025 |
Direct |
Common Stock |
|
| Stock Options (Right to Buy) |
37,050 |
|
|
21 May 2024 |
Direct |
Common Stock |
|
| Series A Non-Voting Convertible Preferred Stock |
0 |
|
|
23 May 2024 |
By Birchview Capital Separately Managed Account |
Common Stock |
|
| Series A Non-Voting Convertible Preferred Stock |
0 |
|
|
23 May 2024 |
By Birchview Fund LLC |
Common Stock |
|
Transactions reported by Matthew Strobeck for BIODESIX INC
| Sym |
Class |
Transaction |
% |
Value $ |
* Price $ |
Shares |
Shares After |
Date |
Ownership |
* An asterisk sign (*) next to the price indicates that the price is likely invalid.